Skip Navigation



Journal of the National Cancer Institute Advance Access published online on April 29, 2008
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djn107
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/9/680    most recent
djn107v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mehta, R. S.
Right arrow Articles by Schubbert, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehta, R. S.
Right arrow Articles by Schubbert, T.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

CORRESPONDENCE

Re: HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials

Rita S. Mehta, Toni Schubbert

Affiliation of authors: School of Medicine, University of California, Irvine, CA

Correspondence to: Rita S. Mehta, MD, Division of Hematology Oncology, Department of Internal Medicine, University of California, Irvine, 101 City Dr, Bldg 56, Rte 81, Orange, CA 92868-3201 (e-mail: rsmehta@uci.edu).

The first 10% of the full text of this article appears below.

Gennari et al. (1) report an interaction between HER2 status and anthracycline chemosensitivity, but they do not mention tumor grade. Multivariable analysis has revealed that . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

Response:Re: HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
Alessandra Gennari, Maria Pia Sormani, Paolo Pronzato, and Paolo Bruzzi
J Natl Cancer Inst 2008 100: 680-681. [Extract] [Full Text] [PDF]